Pharmacologic down-regulation of EZH2 suppresses bladder cancer in vitro and in vivo. [electronic resource]
Producer: 20150730Description: 10342-55 p. digitalISSN:- 1949-2553
- Animals
- Antineoplastic Agents -- administration & dosage
- Apoptosis -- drug effects
- Carcinoma -- drug therapy
- Cell Growth Processes -- drug effects
- Cell Line, Tumor
- Down-Regulation
- Drug Resistance -- drug effects
- Emodin -- administration & dosage
- Enhancer of Zeste Homolog 2 Protein
- G2 Phase Cell Cycle Checkpoints -- drug effects
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- In Vitro Techniques
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Neoadjuvant Therapy
- Neoplasm Staging
- Polycomb Repressive Complex 2 -- antagonists & inhibitors
- Proteasome Endopeptidase Complex -- metabolism
- Urinary Bladder Neoplasms -- drug therapy
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.